Icotinib combined with rapamycin in a renal transplant recipient with epidermal growth factor receptormutated nonsmall cell lung cancer: A case report

Author：        

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.1, 2014-01, pp. : 171-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer

By        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2066-2072

Spandidos Publications

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Signaling in Nonsmall Cell Lung Cancer

By Ganti Apar Kishor  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 515-525

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance

By              

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 393-398

Spandidos Publications

Access to resources Recommend Favorite

Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

By        

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 931-938

Spandidos Publications

Access to resources Recommend Favorite

Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptormutated lung cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2489-2492

Spandidos Publications

Access to resources Recommend Favorite